all 177362 studies found for:    ALL
Show Display Options
RSS Create an RSS feed from your search for:
ALL
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness
Condition: Sleep Initiation and Maintenance Disorders
Intervention: Drug: EVT 201
2 Completed Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Gefitinib;   Drug: Docetaxel;   Drug: Carboplatin;   Drug: Fluorouracil
3 Completed Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn
Condition: Deep Partial Thickness Burn
Intervention: Drug: rhGM-CSF Gel
4 Recruiting Monocentric Registry to Investigate the Role of Platelet Function, Platelet Pharmacogenomics, Proteomics and Metabonomics in Ischemic and Non-ischemic Heart Disease
Condition: Cardiovascular Disease
Intervention:
5 Active, not recruiting Promoting Tolerance to Peanut in High-Risk Children
Conditions: Eczema;   Egg Allergy;   Food Allergy
Intervention: Biological: peanut-containing snack
6 Recruiting Cortisol and Nutritional Sympathetic Responsiveness
Conditions: Metabolic Syndrome;   Obesity;   Insulin Resistance
Interventions: Drug: metyrapone;   Drug: placebo
7 Completed Pelvic Organ Prolapse Repair Plus Mini-Sling Versus Pelvic Organ Prolapse Repair Alone
Conditions: Pelvic Organ Prolapse;   Urinary Incontinence
Interventions: Procedure: POP repair plus mini-sling;   Procedure: POP repair
8 Suspended Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)
Condition: Non Small Cell Lung Cancer
Intervention: Drug: gefitinib
9 Terminated Terminal Graft Failure
Conditions: Orthotopic Heart Transplantation;   Graft Failure
Intervention:
10 Completed Health Assessment Study
Condition: Hypertension
Interventions: Drug: MK0954,   /Duration of Treatment : 16 Weeks;   Drug: Comparator : atenolol /Duration of Treatment : 16 Weeks
11 Withdrawn Phase 2 Study in Adults Sensitized to Short Ragweed
Condition: Allergic Rhinitis
Interventions: Biological: Standardized Allergenic Extract, Short Ragweed (Ambrosia artemisiifolia);   Biological: Placebo
12 Completed An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis
Condition: Cystitis, Interstitial
Interventions: Drug: PF-04383119;   Drug: Placebo
13 Completed Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation
Condition: Aortic Regurgitation
Intervention:
14 Recruiting Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma
Conditions: Refractory Multiple Myeloma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: fludarabine phosphate;   Radiation: total-body irradiation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Drug: bortezomib;   Drug: lenalidomide;   Other: laboratory biomarker analysis
15 Recruiting PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IVA Salivary Gland Cancer;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Salivary Gland Cancer;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Salivary Gland Cancer;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
Interventions: Drug: PI3K inhibitor BKM120;   Biological: cetuximab;   Other: laboratory biomarker analysis;   Other: questionnaire administration
16 Unknown  Adderall XR and Processing Speed in Multiple Sclerosis (MS)
Conditions: Impaired Processing Speed;   Cognitive Impairment;   Multiple Sclerosis
Interventions: Drug: Adderall XR 5mg;   Drug: Adderall XR 10 mg;   Drug: Placebo
17 Completed
Has Results
Lansoprazole 30 mg DR Capsule Replicate Food Study
Condition: Healthy
Interventions: Drug: Lansoprazole;   Drug: Prevacid®
18 Completed
Has Results
Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
Condition: Treatment Resistant Nephrotic Syndrome
Intervention: Drug: ACTHAR gel
19 Completed Predictors of Hospital-Based Care in Asthma
Conditions: Asthma;   Lung Diseases
Intervention:
20 Completed Study in Polish Acromegalic Patients Treated With Somatuline Autogel
Condition: Acromegaly
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years